DNP DNP
Company Profile ↓Company Overview
DNP (DNP) is a publicly traded company listed on with a market capitalization of $3.81B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 8.7.
Maintains a net profit margin of 98.1%.
Carries low leverage with a debt-to-equity ratio of 0.28.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Oct 2025 Revenue of $438.81M (-48.5% YoY); net profit $430.61M.
- Trailing 12 Months Year-on-year growth — revenue -48.5%, earnings -48.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -48.48% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -48.92% |
Stock Price Performance
| 1 Year: | +6.71% |
| 6 Months: | -1.98% |
| 3 Months: | -6.18% |
| 1 Month: | +3.53% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)55.66 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 98.1%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|
| Revenue | -12.82M | -176.87M | 851.71M | 438.81M |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 8.99M | 9.05M | 8.64M | 8.20M |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 30.69M | 56.10M | 61.33M | 54.09M |
| Pretax Income | -21.81M | -185.92M | 843.07M | 430.61M |
| Tax Provision | - | - | - | - |
| Net Income | -21.81M | -185.92M | 843.07M | 430.61M |
| Diluted EPS | -0.01 | -0.47 | 2.31 | 1.16 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|
| Total Assets | 4.22B | 3.82B | 4.44B | 4.64B |
| Current Assets | - | - | - | - |
| Cash & Equivalents | 66.61M | 44.62M | 23.57M | 26.58M |
| Inventory | - | - | - | - |
| Receivables | 15.65M | 17.19M | 33.32M | 15.36M |
| Total Liabilities | 1.16B | 1.14B | 1.14B | 1.14B |
| Current Liabilities | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Total Debt | 896.98M | 972.34M | 972.59M | 972.83M |
| Total Equity | 3.07B | 2.68B | 3.30B | 3.50B |
| Shares Outstanding | 354.38M | 362.54M | 369.51M | 375.80M |
Cash Flows (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 182.22M | 174.15M | 205.45M | 235.88M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -153.63M | -196.14M | -226.50M | -232.87M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 182.22M | 174.15M | 205.45M | 235.88M |
| Net Change in Cash | - | 28.60M | -21.99M | -21.05M | 3.01M |
Ratios (Annual)
Figures in %.
| Metric | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 170.1% | 105.1% | 99.0% | 98.1% |
| ROE % | -0.7% | -6.9% | 25.5% | 12.3% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DNP
Duff & Phelps Utilities Income Fund Price Forecast. Should You Buy DNP? - StockInvest.us
<a href="https://news.google.com/rss/articles/CBMiR0FVX3lxTFBUMnRnc1BRelZwd1FuVUYxTVFrclB1S3RDYmh0ZmVMc2pTQUNXS1JKeFNNSnFHR1QxQ0R0ZEhPcTgwcURtczNB?oc=5" target="_blank">Duff & Phelps Utilities Income Fund Price Forecast. Should You Buy DNP?…
DNP Select Income Fund Inc's Dividend Analysis - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQTDE3MmpIX09GaWdnSTg4WnY3dVc1d2hLU0loaVF6OUdhVmZBQ29NLUItLVBYVGtkUTJkb1J0ZTlzdlA3bWdpU0FPWW9SQWlMbGgxcUt1NXZTckd3NVVnN3hkZWlYUkRfVUpvdFRkdnJ3Z1ZCUnBWVVo1c3cwZEVJZFR6NklKb0w4WElYbU…
DNP stock hits 52-week low at 9.68 USD - Investing.com
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPcmk4c0lSVVZXNGd5NHVxUHU5RXFKYnBpZjVtMEtNNDR1SmFjMUdnWjdKRFo0UnFHUDVnUzNfZzViNmpyQ292ejQxXzNMUlFtVVRLSmR2QWhDeHVtQUlZSzBBTVNtVTJvMWZmMHhNRGYyaXZydGE2UHZEX3ZwTmJkcVZWODlveVRTRk14MG…
The Technical Signals Behind (DNP) That Institutions Follow - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPNEQ1UFVjQmc4TTV2TWxFakRVTFBrLXM4Zko3UlFpUlRqYVM0c1RseDBXaS1zamY1QmFvOTJndGxDQ1lCV1lseVFpcFZENFFpSzlSV0JaYTI5d0l1eW1nc2hQb1dTc0kxU0FGREZTQ3VxZWhwM1hnN1JIaUVYV1Noa1BUNjBVV21KSlNYNk…
ASCO 2026: Mary Steinbach, DNP, APRN, Shares Top Myeloma Highlights - Cancer Nursing Today
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVnNDdmR6eExhdU5veUYtR3JPQjNxYjIxVHBOUmtLZzdVZVdfdzJBWDRldWcwa1M1QWltb0k0VUZvLVV3OERLM1RBdnNESWc4aS1aajg5TFhvRkswTWVMVmhiN2ZyaUtmN2ZFXzhnamMwN2ViXzJCUFFWV0FKbEc5OG11Zm9VQl80WENlcl…
DNP Select Income Fund (NYSE:DNP) Reaches New 12-Month Low - Here's Why - MarketBeat
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxOUjlGejJKUUF3cWlmQlVWSkZQaVl3Y29wYzZxNFBTYjJIYjR3d1JnMElhdUo5aWIxQnlmUktFZU03LVNjS1ZkQVNMVm1uTjJrbElqbDY3d2h2NWtlTV9abHNyTEpYNjFoODhtZXNLSkEzRFoxWm1KUk1KdnhIN0g2TVhKc0xjTmFzRXZhcS…
DNP — Frequently Asked Questions
What is the current share price of DNP?
As of 2026-10-23 16:27 PDT, DNP trades at $10.13 on NASDAQ/NYSE. Its 52-week range is $9.30 to $10.91.
What is the market capitalisation of DNP?
DNP has a market capitalisation of $3.81B on NASDAQ/NYSE.
What is the P/E ratio of DNP?
DNP trades at a trailing price-to-earnings (P/E) ratio of 8.73. Its price-to-book (P/B) ratio is 1.09.
What is the return on equity (ROE) of DNP?
DNP has a return on equity (ROE) of 12.31%.
Is DNP a good stock to buy?
This page provides a data-driven analysis of DNP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.